 |
|
|
 |
|
FDA Approves New Drug for Severe Epilepsy
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 Most children with Lennox-Gastaut syndrome have some degree of impaired intellectual functioning or information processing, as well as developmental delays and behavioral issues.
"This approval offers another treatment option for patients who suffer from these debilitating, severe seizures," Dr. Russell Katz, director of the division of neurology products in the FDA's Center for Drug Evaluation and Research, said in the news release.
More information
Text Continues Below

Epilepsy Ontario has more about Lennox-Gastaut syndrome.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 11/21/2008
|
 |

SOURCE: U.S. Food and Drug Administration news release, Nov. 21, 2008
|